Index
Module 3 • Clinical Pharmacology
Fluids, Electrolytes, Acid-Base & Nutrition
90%
Core Content
Fluids, Electrolytes, Acid-Base & Nutrition
Ashley Hawthorne ~3 min read Module 3 of 20
56
/ 62

Fluids, Electrolytes, Acid-Base Disorders, and Nutrition Support

ASPEN Adult Nutrition Support Core Curriculum.

American Society for Parenteral and Enteral Nutrition;

2012:580-602.

Nicolo M, Heyland DK, Chittams J, Sammarco

T,

Compher

C.

Clinical

outcomes

related

to

protein delivery in a critically ill population: a mul-

ticenter, multinational observation study. JPEN J

Parenter Enteral Nutr. 2016;40(1):45-51. https://doi.

org/10.1177/0148607115583675

Olson LM, Wieruszewski PM, Jannetto PJ, Abbott JC,

McMahon MM, Nystrom EM. Quantitative assess-

ment of trace-element contamination in parenteral

nutrition components. JPEN J Parenter Enteral Nutr.

2019;43(8):970-976. https://doi.org/10.1002/jpen.1668

Osterkamp LK. Current perspective on assessment of

human body proportions of relevance to amputees. J Am

Diet Assoc. 1995;95(2):215-218. https://doi.org/10.1016/

s0002-8223(95)00050-x

Howard L, Parnes EA, Mascioli CL, et al. Parenteral

nutrition in overweight patients: are intravenous lipids

necessary to prevent essential fatty acid deficiency? J

Nutr Biochem. 1994;5(5):243-247.

Parrish CR, O’Donnell K. Copper deficiency: like a bad

penny. Pract Gastroenterol. 2020;44:24-32.

Pirola I, Daffini L, Gandossi E, et al. Comparison

between liquid and tablet levothyroxine formula-

tions in patients treated through enteral feeding tube.

J Endocrinol Invest. 2014;37(6):583-587. https://doi.

org/10.1007/s40618-014-0082-9

Puder M, Valim C, Meisel JA, et al. Parenteral fish oil

improves outcomes in patients with parenteral nutrition-

associated liver injury. Ann Surg. 2009;250(3):395-402.

https://doi.org/10.1097/sla.0b013e3181b36657

Reignier J, Plantefeve G, Mira JP, et al. Low versus

standard calorie and protein feeding in ventilated adults

with shock: a randomised, controlled, multicentre,

open-label, parallel-group trial (NUTRIREA-3). Lancet

Respir Med. 2023;11(7):602-612. https://doi.org/10.1016/

s2213-2600(23)00092-9

Rhodes A, Evans LE, Alhazzani W, et al. Surviving

Sepsis Campaign: international guidelines for man-

agement of sepsis and septic shock: 2016. Crit Care

Med.

2017;45(3):486-552.

https://doi.org/10.1097/

ccm.0000000000002255

Rosmarin

DK,

Wardlaw

GM,

Mirtallo

J.

Hyperglycemia

associated

with

high,

continu-

ous infusion rates of total parenteral nutrition

dextrose. Nutr Clin Pract. 1996;11(4):151-156. https://doi.

org/10.1177/0115426596011004151

Russell MK, Wischmeyer PE. Supplemental parenteral

nutrition: review of the literature and current nutrition

guidelines. Nutr Clin Pract. 2018;33(3):359-369. https://

doi.org/10.1002/ncp.10096

Sheldon GF, Peterson SR, Sanders R. Hepatic dys-

function

during

hyperalimentation.

Arch

Surg.

1978;113(4):504-508.

https://doi.org/10.1001/

archsurg.1978.01370160162028

Shike M, Roulet M, Kurian R, Whitwell J, Stewart

S, Jeejeebhoy KN. Copper metabolism and require-

ments in total parenteral nutrition. Gastroenterology.

1981;81(2):290-297.

Singer P, Blaser AR, Berger MM, et al. ESPEN practi-

cal and partially revised guideline: clinical nutrition in

the intensive care unit. Clin Nutr. 2023;42(9):1671-1689.

https://doi.org/10.1016/j.clnu.2023.07.011

Takagi Y, Okada A, Sando K, Wasa M, Yoshida H,

Hirabuki N. Evaluation of indexes of in vivo manganese

status and the optimal intravenous dose for adult patients

undergoing home parenteral nutrition. Am J Clin Nutr.

2002;75(1):112-118. https://doi.org/10.1093/ajcn/75.1.112

Talpers SS, Romberger DJ, Bunce SB, Pingleton SK.

Nutritionally associated increased carbon dioxide pro-

duction. Excess total calories vs high proportion of

carbohydrate calories. Chest. 1992;102(2):551-555.

https://doi.org/10.1378/chest.102.2.551

Tillman

EM.

Review

and

clinical

update

on

parenteral

nutrition-associated

liver

disease. Nutr Clin Pract. 2013;28(1):30-39. https://doi.

org/10.1177/0884533612462900

Vandewoude K, Vogelaers D, Decruyenaere J, et al.

Concentrations in plasma and safety of 7 days of

intravenous itraconazole followed by 2 weeks of oral

itraconazole solution in patients in intensive care units.

Antimicrob Agents Chemother. 1997;41(12):2714-2718.

https://doi.org/10.1128/aac.41.12.2714

Vriesendorp TM, van Santen S, DeVries JH, et al.

Predisposing factors for hypoglycemia in the intensive

care unit. Crit Care Med. 2006;34(1):96-101. https://doi.

org/10.1097/01.ccm.0000194536.89694.06

HD Video Explanation β€” Synchronized with PDF
Starts at: minute 55 Open on YouTube